DE60305339D1 - 3-(cyclopenten-1-yl)-benzyl- oder 3-(cyclopenten-1-yl)heteroarylmethylaminderivate und deren verwendung als arzneimittel zur behandlung von schizophrenie - Google Patents

3-(cyclopenten-1-yl)-benzyl- oder 3-(cyclopenten-1-yl)heteroarylmethylaminderivate und deren verwendung als arzneimittel zur behandlung von schizophrenie

Info

Publication number
DE60305339D1
DE60305339D1 DE60305339T DE60305339T DE60305339D1 DE 60305339 D1 DE60305339 D1 DE 60305339D1 DE 60305339 T DE60305339 T DE 60305339T DE 60305339 T DE60305339 T DE 60305339T DE 60305339 D1 DE60305339 D1 DE 60305339D1
Authority
DE
Germany
Prior art keywords
cyclopenten
benzyl
heteroarylmethylamine
schizophrenia
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60305339T
Other languages
English (en)
Other versions
DE60305339T2 (de
Inventor
Bernard Vacher
Stephane Cuisiat
Wouter Koek
Francis Colpaert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of DE60305339D1 publication Critical patent/DE60305339D1/de
Publication of DE60305339T2 publication Critical patent/DE60305339T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/548—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings having unsaturation outside the six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/55—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/48—Aldehydo radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
DE60305339T 2002-10-16 2003-10-16 3-(cyclopenten-1-yl)-benzyl- oder 3-(cyclopenten-1-yl)heteroarylmethylaminderivate und deren verwendung als arzneimittel zur behandlung von schizophrenie Expired - Lifetime DE60305339T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0212854A FR2845992B1 (fr) 2002-10-16 2002-10-16 Derives de 3-(cyclopenten-1yl)-benzyl-ou3-(cyclopenten-1yl)- heteroarylmethyl-amines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie
FR0212854 2002-10-16
PCT/FR2003/003053 WO2004035561A1 (fr) 2002-10-16 2003-10-16 Derives de 3-(cyclopenten-1-yl)-benzyl- ou 3-(cyclopenten-1-yl)-heteroarylmethyl-amines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie

Publications (2)

Publication Number Publication Date
DE60305339D1 true DE60305339D1 (de) 2006-06-22
DE60305339T2 DE60305339T2 (de) 2007-02-01

Family

ID=32050432

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60305339T Expired - Lifetime DE60305339T2 (de) 2002-10-16 2003-10-16 3-(cyclopenten-1-yl)-benzyl- oder 3-(cyclopenten-1-yl)heteroarylmethylaminderivate und deren verwendung als arzneimittel zur behandlung von schizophrenie

Country Status (16)

Country Link
US (2) US7163957B2 (de)
EP (1) EP1551821B1 (de)
JP (1) JP4566749B2 (de)
CN (1) CN1319962C (de)
AT (1) ATE326456T1 (de)
AU (1) AU2003301277B2 (de)
BR (1) BR0315365A (de)
CA (1) CA2502528C (de)
DE (1) DE60305339T2 (de)
ES (1) ES2264780T3 (de)
FR (1) FR2845992B1 (de)
HK (1) HK1073112A1 (de)
MX (1) MXPA05004114A (de)
PT (1) PT1551821E (de)
WO (1) WO2004035561A1 (de)
ZA (1) ZA200503822B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2898601A1 (fr) * 2006-03-14 2007-09-21 Pierre Fabre Medicament Sa Procede de preparation de derives (2-(2,3-dihydro-benzofuran ou benzofuran-7-yloxy)-ethyl)-(3-cyclopenten-1-yl-benzyl) amines et intermediaire de synthese
US20090288701A1 (en) * 2008-05-23 2009-11-26 E.I.Du Pont De Nemours And Company Solar cell laminates having colored multi-layer encapsulant sheets

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05125024A (ja) * 1991-11-05 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアリールオキシアルキルアミン誘導体又はその塩
JPH05255302A (ja) * 1992-03-09 1993-10-05 Yamanouchi Pharmaceut Co Ltd 新規なクロマニルオキシアルキルアミン誘導体
US5955495A (en) * 1996-05-03 1999-09-21 Hoffmann-La Roche Inc. Method of treating diseases of the CNS
PT923551E (pt) * 1996-08-27 2002-09-30 American Home Prod Derivados de 4-aminoetoxi indolona
WO1999051575A1 (en) * 1998-04-08 1999-10-14 American Home Products Corporation N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
WO1999058527A2 (en) * 1998-05-14 1999-11-18 EGIS Gyógyszergyár Rt. Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
FR2791676B1 (fr) * 1999-03-29 2001-06-22 Pf Medicament Nouveaux derives de [(2-substitue-5-[thienyl])-benzyl]- [2-([isopropoxy-5-fluoro]-phenoxy) ethyl]-amine, leur procede de preparation et leur utilisation a titre de medicaments

Also Published As

Publication number Publication date
AU2003301277A1 (en) 2004-05-04
EP1551821A1 (de) 2005-07-13
CA2502528C (fr) 2011-12-13
AU2003301277B2 (en) 2009-06-18
HK1073112A1 (en) 2005-09-23
CA2502528A1 (fr) 2004-04-29
ZA200503822B (en) 2006-03-29
US7163957B2 (en) 2007-01-16
US20060014827A1 (en) 2006-01-19
BR0315365A (pt) 2005-08-23
FR2845992B1 (fr) 2005-02-04
US20060264471A1 (en) 2006-11-23
ATE326456T1 (de) 2006-06-15
DE60305339T2 (de) 2007-02-01
JP4566749B2 (ja) 2010-10-20
WO2004035561A1 (fr) 2004-04-29
CN1705653A (zh) 2005-12-07
FR2845992A1 (fr) 2004-04-23
JP2006508080A (ja) 2006-03-09
PT1551821E (pt) 2006-09-29
US7235568B2 (en) 2007-06-26
ES2264780T3 (es) 2007-01-16
MXPA05004114A (es) 2005-06-22
EP1551821B1 (de) 2006-05-17
CN1319962C (zh) 2007-06-06

Similar Documents

Publication Publication Date Title
RU2328494C2 (ru) Замещенные пиперазины, (1,4)-диазепины и 2,5-диазабицикло[2.2.1]гептаны в качестве н1-и/или н3-антагонистов гистамина или обратных н3-антагонистов гистамина
ATE461188T1 (de) Verstärker von glutamat-rezeptoren
TW200510441A (en) Novel compounds
NO20056130L (no) Nye substituerte 3-svovelindoler
CY1108228T1 (el) Διαρυλ-αιθερες, ως ανταγωνιστης οπιοειδους υποδοχεως
DE60319865D1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
EA200600925A1 (ru) Производные триазола в качестве антагонистов вазопрессина
NO20000521D0 (no) 1-(N-fenylaminoalkyl)-piperazin derivater substituert i posisjon 2 på fenylringen
HUP0103988A2 (en) New d3-dopamine receptor selective piperazine and piperidine compounds, process for their preparation, their and pharmaceutical compositions containing them
EA200600348A1 (ru) Новые соединения
ATE520693T1 (de) Spirocyclische cyclohexanderivate mit analgesischer wirkung
ATE277072T1 (de) Sapogenin derivate zur behandlung von kognitiven störungen
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
ATE249457T1 (de) Indolderivate und ihre verwendung als serotoninrezeptor-liganden
DE60111464D1 (de) Azabicycloalkan-Derivate zur Verwendung als Inhibitoren der Serotonin-Wiederaufnahme und als 5HT2a Antagonisten
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
DE60305339D1 (de) 3-(cyclopenten-1-yl)-benzyl- oder 3-(cyclopenten-1-yl)heteroarylmethylaminderivate und deren verwendung als arzneimittel zur behandlung von schizophrenie
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600455A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600456A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
ATE455769T1 (de) Substituierte thiazole und ihre verwendung zur herstellung von arzneimitteln
BR0104344A (pt) Análagos de fenoxazina úteis como inibidores de agregação amilóide e tratamento da doença de alzheimer e de disfunções relacionadas com a amiloidose
EA200600249A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей

Legal Events

Date Code Title Description
8364 No opposition during term of opposition